When a patch of brain gets busy, it pulls in extra blood within a second or two. A study in mice now pins part of that traffic control on substance P, a small peptide better known for carrying pain and nausea signals.
The matching of blood to activity is called neurovascular coupling, and it is one of the quiet essentials of a working brain. The brain cannot store fuel, so it constantly redirects blood to whichever regions are firing. That same coupling is what brain scanners measure when they show a region "lighting up," and it is one of the first things to break down in Alzheimer's disease, stroke, and small-vessel disease. Knowing which molecular switches control it is a way of finding places to intervene.
The work, published July 3 in Science Advances ↗, used two-photon imaging, a microscopy method that watches living brain tissue in real time, in the mouse cortex. The team followed a small group of cells it calls Tacr1 neurons, a subset of somatostatin neurons named for the receptor they carry. That receptor, TACR1 ↗, also called the neurokinin-1 receptor, is the docking site for substance P ↗, the eleven-amino-acid peptide RPKPQQFFGLM. Despite being a minority of the neurons present, these cells turned out to hold an outsized grip on local blood flow.
The peptide, then the gas, then the vessel
The mechanism runs in a short line. When substance P binds the TACR1 receptor on these neurons, the cells release nitric oxide, a gas that relaxes the muscle wrapped around nearby blood vessels and widens them. Wider vessels carry more blood. The same neurons carry neuronal nitric oxide synthase (nNOS), the enzyme that makes the gas, so the peptide signal and the vasodilator sit inside one cell rather than being handed between cells.
The team also traced where the substance P comes from. Some is released locally, mostly by parvalbumin neurons, a common inhibitory cell type, and some arrives on long-range fibers reaching in from the perirhinal cortex, a region tied to memory. The parvalbumin neurons only moved blood flow when the Tacr1 neurons were intact, which puts the Tacr1 cell at the center of the circuit rather than at its edge.
The part that argues with the textbook
For years astrocytes, the brain's star-shaped support cells, have been prime suspects in controlling blood flow, because they show surges of calcium right around the time vessels dilate. This study flips the order. The astrocyte calcium surge arrived after the vessels had already widened, not before, which makes it a consequence of the dilation rather than its trigger. That is the sentence in the paper worth arguing with, because a lot of models of brain blood flow have leaned on astrocytes as a driver.
There are limits. This is mouse cortex, and it is a mechanism paper, not a treatment. Substance P is hard to reach in the living brain, and the receptor blockers built from this pathway (used against chemotherapy nausea) do not cleanly enter healthy brain tissue. But the result narrows the search. If failing blood-flow control is part of what drives cognitive decline in small-vessel disease, the substance P to nitric oxide step is now a specific place to look, and it sits on a receptor peptidemodel already tracks as a target with substance P itself hosted as a card.